Androgen insensitivity syndrome classification: Difference between revisions
No edit summary |
|||
Line 9: | Line 9: | ||
Androgen insensitivity syndrome (AIS) represents a spectrum of defects in androgen action and can be subdivided into three broad phenotypes:<ref name="pmid20301602">{{cite journal |vauthors=Pagon RA, Adam MP, Ardinger HH, Wallace SE, Amemiya A, Bean LJH, Bird TD, Ledbetter N, Mefford HC, Smith RJH, Stephens K, Gottlieb B, Trifiro MA |title= |journal= |volume= |issue= |pages= |year= |pmid=20301602 |doi= |url=}}</ref> | Androgen insensitivity syndrome (AIS) represents a spectrum of defects in androgen action and can be subdivided into three broad phenotypes:<ref name="pmid20301602">{{cite journal |vauthors=Pagon RA, Adam MP, Ardinger HH, Wallace SE, Amemiya A, Bean LJH, Bird TD, Ledbetter N, Mefford HC, Smith RJH, Stephens K, Gottlieb B, Trifiro MA |title= |journal= |volume= |issue= |pages= |year= |pmid=20301602 |doi= |url=}}</ref> | ||
*Complete androgen insensitivity syndrome (CAIS), with typical female external genitalia | *'''''Complete androgen insensitivity syndrome (CAIS)''''', with typical female external genitalia | ||
*Partial androgen insensitivity syndrome (PAIS) with predominantly female, predominantly male, or ambiguous external genitalia | *'''''Partial androgen insensitivity syndrome (PAIS)''''' with predominantly female, predominantly male, or ambiguous external genitalia | ||
*Mild androgen insensitivity syndrome (MAIS) with typical male external genitalia | *'''''Mild androgen insensitivity syndrome (MAIS)''''' with typical male external genitalia | ||
{| style="border: 0px; font-size: 90%; margin: 3px;" align="center" | |||
{| style="border: 0px; font-size: 90%; margin: 3px;" align=center | |||
| colspan="3" style="background: #4479BA; text-align: center;" | {{fontcolor|#FFF|'''Classification of Androgen Insensitivity Syndrome Phenotypes'''}} | | colspan="3" style="background: #4479BA; text-align: center;" | {{fontcolor|#FFF|'''Classification of Androgen Insensitivity Syndrome Phenotypes'''}} | ||
|+ | |+ | ||
! style="background: #4479BA; padding: 5px 5px;" | ! rowspan="1" style="background: #4479BA; padding: 5px 5px;" | {{fontcolor|#FFFFFF|Type}} | ||
! style="background: #4479BA; padding: 5px 5px;" | ! rowspan="1" style="background: #4479BA; padding: 5px 5px;" | {{fontcolor|#FFFFFF|External Genitalia}} | ||
! style="background: #4479BA; padding: 5px 5px;" | ! colspan="1" style="background: #4479BA; padding: 5px 5px;" | {{fontcolor|#FFFFFF|Findings}} | ||
|- | |- | ||
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold | | rowspan="2;" style="padding: 5px 5px; background: #DCDCDC; font-weight: bold;" | CAIS - (Complete androgen insensitivity syndrome) | ||
| style="padding: 5px 5px; background: #F5F5F5;" | Female (“testicular feminization”) | | style="padding: 5px 5px; background: #F5F5F5;" | Female (“testicular feminization”) | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
Line 36: | Line 35: | ||
*Distinct urethral and vaginal openings OR a urogenital sinus. | *Distinct urethral and vaginal openings OR a urogenital sinus. | ||
|- | |- | ||
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold | | rowspan="2;" style="padding: 5px 5px; background: #DCDCDC; font-weight: bold;" | PAIS - (Partial androgen insensitivity syndrome) | ||
| style="padding: 5px 5px; background: #F5F5F5;" | Ambiguous | | style="padding: 5px 5px; background: #F5F5F5;" | Ambiguous | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
Line 49: | Line 48: | ||
*Gynecomastia in puberty. | *Gynecomastia in puberty. | ||
|- | |- | ||
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold | | rowspan="1;" style="padding: 5px 5px; background: #DCDCDC; font-weight: bold;" | MAIS - (Mild androgen insensitivity syndrome) | ||
| style="padding: 5px 5px; background: #F5F5F5;" | Male (“undervirilized male syndrome”) | | style="padding: 5px 5px; background: #F5F5F5;" | Male (“undervirilized male syndrome”) | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | |
Revision as of 22:27, 15 August 2017
Androgen insensitivity syndrome Microchapters |
Differentiating Androgen insensitivity syndrome from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Androgen insensitivity syndrome classification On the Web |
American Roentgen Ray Society Images of Androgen insensitivity syndrome classification |
Directions to Hospitals Treating Androgen insensitivity syndrome |
Risk calculators and risk factors for Androgen insensitivity syndrome classification |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aravind Reddy Kothagadi M.B.B.S[2]
Overview
Androgen insensitivity syndrome (AIS) represents a spectrum of defects in androgen action and can be subdivided into three broad phenotypes such as CAIS. PAIS and MAIS.
Classification
Androgen insensitivity syndrome (AIS) represents a spectrum of defects in androgen action and can be subdivided into three broad phenotypes:[1]
- Complete androgen insensitivity syndrome (CAIS), with typical female external genitalia
- Partial androgen insensitivity syndrome (PAIS) with predominantly female, predominantly male, or ambiguous external genitalia
- Mild androgen insensitivity syndrome (MAIS) with typical male external genitalia
Classification of Androgen Insensitivity Syndrome Phenotypes | ||
Type | External Genitalia | Findings |
---|---|---|
CAIS - (Complete androgen insensitivity syndrome) | Female (“testicular feminization”) |
|
Predominantly female (“incomplete AIS”) |
| |
PAIS - (Partial androgen insensitivity syndrome) | Ambiguous |
|
Predominantly male |
| |
MAIS - (Mild androgen insensitivity syndrome) | Male (“undervirilized male syndrome”) |
|